Related Experiment Video
Updated: Jun 16, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial
David S Yee1, Darren J Katz, Guilherme Godoy
1Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. yeed1@mskcc.org
Urology
|February 19, 2010
Summary
Extended pelvic lymph node dissection (ePLND) during robotic-assisted radical prostatectomy (RARP) is feasible and safe. This technique increases lymph node yield, potentially improving cancer staging with minimal complications.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Pelvic lymphadenectomy extent in radical prostatectomy is not standardized.
- Extended pelvic lymph node dissection (ePLND) may increase positive node detection.
Purpose of the Study:
- To describe the technique for ePLND during robotic-assisted radical prostatectomy (RARP).
- To report clinicopathologic and perioperative outcomes of ePLND in RARP.
Main Methods:
- 32 patients with localized prostate cancer underwent RARP with ePLND by a single surgeon.
- ePLND template included obturator, hypogastric, external iliac, and common iliac nodes up to the aortic bifurcation.
- Systematic review and grading of adverse events were performed.
Main Results:
- Median 18 lymph nodes retrieved; 12.5% of patients had metastases.
- Median operative time for ePLND was 72 minutes; median hospital stay was 2.0 days.
- Complications were minimal, with no lymphoceles or thrombotic events.
Conclusions:
- ePLND during RARP is technically feasible with minimal morbidity.
- The procedure yields a high number of lymph nodes, potentially improving pathologic staging.
